We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > blood pressure drugs

News List

A third cancer-causing impurity detected in U.S. supply of blood pressure drugs fiercepharma
March 05, 2019
Just when it appeared the FDA was close to purging the U.S. drug supply of potential cancer-causing impurities in sartan blood pressure drugs, another massive recall has been launched. This time it is for an entirely new contaminant.
Mylan recalls all lots of blood pressure drugs containing valsartan pharmaceutical-technology
December 10, 2018
Mylan has expanded the consumer-level voluntary recall of all lots of valsartan-containing drugs within expiry in the US after finding trace amounts of an impurity called N-nitrosodiethylamine (NDEA).....